Literature DB >> 27330755

The role of microRNAs in gallbladder cancer.

Ganghua Yang1, Lei Zhang1, Ruixiang Li1, Lin Wang1.   

Abstract

MicroRNAs (also referred to as miRNAs or miRs) play a crucial role in post-transcriptional gene regulation and serve as negative gene regulators by controlling a variety of target genes and regulating diverse biological processes, such as cell proliferation, invasion, migration and apoptosis. Aberrant expression of miRNAs is associated with the development and progression of cancer. Recent studies have reported that miRNAs may repress or promote the expression of cancer-related genes via several different signaling pathways in gallbladder cancer (GBC) patients and may function as tumor suppressors or oncogenes, thus providing a promising tool for the diagnosis and therapeutics of GBCs. In this review, we summarize the role of dysregulawted miRNA expression in the signaling pathways implicated in GBC and discuss the significant role of circulating miRNAs in GBC. Therefore, miRNAs may serve as novel therapeutic targets as well as diagnostic or prognostic markers in GBC.

Entities:  

Keywords:  biomarker; gallbladder cancer; microRNA; therapeutic target

Year:  2016        PMID: 27330755      PMCID: PMC4906925          DOI: 10.3892/mco.2016.905

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  97 in total

1.  Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.

Authors:  Kshitij Srivastava; Anvesha Srivastava; Balraj Mittal
Journal:  J Hum Genet       Date:  2010-06-03       Impact factor: 3.172

Review 2.  Outcomes in biliary malignancy.

Authors:  Bas Groot Koerkamp; Yuman Fong
Journal:  J Surg Oncol       Date:  2014-10       Impact factor: 3.454

3.  MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.

Authors:  Xin Yang; Xiao-Fei Zhang; Xu Lu; Hu-Liang Jia; Lei Liang; Qiong-Zhu Dong; Qing-Hai Ye; Lun-Xiu Qin
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

4.  Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion.

Authors:  Jinjin Yu; Yuan Wang; Ruofan Dong; Xiaoyan Huang; Suning Ding; Haifeng Qiu
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

5.  Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.

Authors:  Steven R Alberts; Hani Al-Khatib; Michelle R Mahoney; Lawerence Burgart; Peter J Cera; Patrick J Flynn; Tom R Finch; Ralph Levitt; Harold E Windschitl; James A Knost; Loren K Tschetter
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

6.  MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome.

Authors:  Yoshitsugu Mitani; Dianna B Roberts; Hanadi Fatani; Randal S Weber; Merrill S Kies; Scott M Lippman; Adel K El-Naggar
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

7.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

8.  Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer.

Authors:  Ming-Zhe Ma; Chun-Xiao Li; Yan Zhang; Ming-Zhe Weng; Ming-di Zhang; Yi-Yu Qin; Wei Gong; Zhi-Wei Quan
Journal:  Mol Cancer       Date:  2014-06-23       Impact factor: 27.401

9.  Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma.

Authors:  Chengli Du; Xiaoyu Weng; Wendi Hu; Zhen Lv; Heng Xiao; Chaofeng Ding; Owusu-Anash K Gyabaah; Haiyang Xie; Lin Zhou; Jian Wu; Shusen Zheng
Journal:  J Exp Clin Cancer Res       Date:  2015-06-28

10.  Locally Advanced, Unresectable Squamous Cell Carcinoma of the Gallbladder.

Authors:  Timothy J Weatherall; Moon Fenton; Gitonga Munene; Paxton V Dickson; Jeremiah L Deneve
Journal:  Case Rep Surg       Date:  2015-07-06
View more
  5 in total

1.  Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer.

Authors:  Ganghua Yang; Zhengyang Lu; Fandi Meng; Yong Wan; Lei Zhang; Qinhong Xu; Zheng Wang
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

Review 2.  Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks.

Authors:  Sunwang Xu; Ming Zhan; Jian Wang
Journal:  Cell Death Discov       Date:  2017-11-27

3.  The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.

Authors:  Mingdi Zhang; Wei Gong; Bin Zuo; Bingfeng Chu; Zhaohui Tang; Yong Zhang; Yong Yang; Di Zhou; Mingzhe Weng; Yiyu Qin; Mingzhe Ma; Alex Jiang; Fei Ma; Zhiwei Quan
Journal:  Oncotarget       Date:  2016-11-29

Review 4.  The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.

Authors:  Nina Nayara Ferreira Martins; Kelly Cristina da Silva Oliveira; Amanda Braga Bona; Marília de Arruda Cardoso Smith; Geraldo Ishak; Paulo Pimentel Assumpção; Rommel Rodríguez Burbano; Danielle Queiroz Calcagno
Journal:  Gastroenterol Res Pract       Date:  2016-12-27       Impact factor: 2.260

Review 5.  Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.

Authors:  Gianluca Rompianesi; Marcello Di Martino; Alex Gordon-Weeks; Roberto Montalti; Roberto Troisi
Journal:  World J Gastrointest Oncol       Date:  2021-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.